|Articles|February 25, 2007
Oriana Schwindt
Advertisement
Oriana Schwindt
Associate Editor
Oriana Schwindt worked as a reporter, writer, and researcher at several national publications (among them, BusinessWeek and Entertainment Weekly) before joining the Pharm Exec team as Associate Editor. She holds a BS in Journalism from the Medill School of Journalism at Northwestern University.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
